How Long Do You Take Xtandi for Prostate Cancer?

Xtandi, known generically as enzalutamide, is an oral medication used to treat advanced prostate cancer that no longer responds to standard hormone therapy. As patients begin this treatment, one of the most common questions concerns how long they will need to take it. The answer varies considerably from person to person and depends on multiple clinical factors that your healthcare team will monitor throughout your treatment journey.

Understanding Xtandi Treatment Over Time

Xtandi works by blocking androgens from binding to cancer cells, which helps slow or stop the growth of prostate cancer. Unlike some medications taken for a fixed period, Xtandi is typically continued as long as it remains effective and tolerable. This means treatment duration is highly individualized. Some patients may take Xtandi for several years, while others might experience disease progression or side effects that necessitate a change in therapy sooner. Clinical trials have shown that patients can benefit from Xtandi for extended periods, with median treatment durations ranging from 16 to 20 months in various studies, though many individuals continue far longer. Your oncologist will regularly assess your PSA levels, imaging results, and overall health to determine whether continuing Xtandi remains the best approach for your specific situation.

Is Xtandi Usually Taken for Life

While some patients do take Xtandi for many years, it is not necessarily a lifelong medication for everyone. The duration depends on whether the cancer continues to respond to treatment and whether the medication remains well-tolerated. Prostate cancer can eventually develop resistance to Xtandi, meaning the medication becomes less effective over time. When this happens, your doctor will likely recommend transitioning to a different treatment approach. Additionally, some patients experience side effects such as fatigue, dizziness, or cardiovascular issues that may require dose adjustments or discontinuation. The goal is always to balance cancer control with quality of life, so treatment plans are regularly reassessed. It is important to maintain open communication with your healthcare team about how you are feeling physically and emotionally throughout your treatment course.

When Might Treatment Be Changed or Stopped

Several circumstances can lead to changing or stopping Xtandi treatment. The most common reason is disease progression, indicated by rising PSA levels, new metastases on imaging scans, or worsening symptoms. When cancer becomes resistant to Xtandi, your oncologist will discuss alternative therapies such as chemotherapy, other hormonal agents, or newer targeted treatments. Side effects also play a significant role in treatment decisions. If you experience severe fatigue, falls due to dizziness, seizures, or other serious adverse effects, your doctor may reduce the dose or switch to a different medication. In some cases, patients with very slow-growing cancer and minimal disease burden might take treatment breaks, though this is less common with advanced prostate cancer. Regular monitoring through blood tests, imaging, and physical examinations helps your healthcare team identify the right time to adjust your treatment plan before problems become severe.

Other Options When Xtandi Is Not the Only Approach

Prostate cancer treatment often involves multiple strategies used either sequentially or in combination. When Xtandi alone is insufficient or becomes less effective, several alternatives exist. Chemotherapy drugs like docetaxel or cabazitaxel may be recommended, particularly if the cancer has become castration-resistant and aggressive. Other hormonal therapies such as abiraterone acetate work through different mechanisms and might be effective when Xtandi is not. Newer treatments including PARP inhibitors for patients with certain genetic mutations, immunotherapy options, and radium-223 for bone metastases provide additional avenues for disease control. Clinical trials also offer access to experimental therapies that may provide benefits when standard treatments have been exhausted. Your oncologist will consider your cancer characteristics, previous treatments, overall health, and personal preferences when recommending the next steps in your care journey.

Discussing Duration and Expectations with Your Care Team

Open and ongoing communication with your healthcare providers is essential when taking Xtandi. Before starting treatment, ask your oncologist what they expect regarding treatment duration based on your specific cancer stage and characteristics. Understand what signs might indicate the medication is working or failing, so you know what to watch for between appointments. Discuss potential side effects and strategies for managing them, as tolerating treatment well often allows for longer duration of therapy. Schedule regular follow-up appointments to review test results and assess how you are responding. Do not hesitate to contact your care team between visits if you experience new symptoms or have concerns about continuing treatment. Many patients find it helpful to bring a list of questions to appointments and to have a family member or friend present to help remember important information. Your medical team wants to partner with you in making decisions that balance cancer control with maintaining the best possible quality of life throughout your treatment course.

Navigating prostate cancer treatment with Xtandi requires patience, regular monitoring, and collaborative decision-making with your healthcare team. While there is no universal answer to how long you will take this medication, understanding the factors that influence treatment duration empowers you to participate actively in your care and make informed decisions as your situation evolves.